Zhejiang CONBA Pharmaceutical (600572.SS) Earnings Analysis
Zhejiang CONBA Pharmaceutical (600572.SS) has no confirmed upcoming earnings date. Trailing P/E 22.57.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 600572.SS next report earnings?
No confirmed upcoming earnings date is currently scheduled for 600572.SS. This page updates as the calendar is published.
600572.SS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-04-24 | 0.04176 CNY | n/a | n/a | n/a |
| 2024-08-23 | 0.06308 CNY | n/a | n/a | n/a |
600572.SS valuation and analyst view
| Trailing P/E | 22.57 |
|---|---|
| Trailing EPS | 0.19001 CNY |
| Price / book | 1.51 |
| Dividend yield | 3.48% |
| Market cap | 10.92B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Zhejiang CONBA Pharmaceutical (600572.SS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 600572.SS. This page updates as the calendar is published.
Did 600572.SS beat earnings last quarter?
Consensus estimate data was not available for 600572.SS's 2025-04-24 report.
What is 600572.SS's current P/E ratio and EPS?
600572.SS trades at a trailing P/E of 22.57 on trailing EPS of 0.1900053597574333 CNY.
What do analysts rate 600572.SS?
600572.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.